留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码
x

乳腺良恶性病变鉴别的MRI影像组学预测模型构建:基于随机森林、支持向量机、逻辑回归分类器

吴佩琪 杨雅俪 周妍璐 郭粉玲 毛小明

吴佩琪, 杨雅俪, 周妍璐, 郭粉玲, 毛小明. 乳腺良恶性病变鉴别的MRI影像组学预测模型构建:基于随机森林、支持向量机、逻辑回归分类器[J]. 分子影像学杂志, 2021, 44(5): 764-770. doi: 10.12122/j.issn.1674-4500.2021.05.07
引用本文: 吴佩琪, 杨雅俪, 周妍璐, 郭粉玲, 毛小明. 乳腺良恶性病变鉴别的MRI影像组学预测模型构建:基于随机森林、支持向量机、逻辑回归分类器[J]. 分子影像学杂志, 2021, 44(5): 764-770. doi: 10.12122/j.issn.1674-4500.2021.05.07
WU Peiqi, YANG Yali, ZHOU Yanlu, GUO Fenling, MAO Xiaoming. Construction of MRI radiomic prediction models for the differentiation of benign and malignant lesions of breast[J]. Journal of Molecular Imaging, 2021, 44(5): 764-770. doi: 10.12122/j.issn.1674-4500.2021.05.07
Citation: WU Peiqi, YANG Yali, ZHOU Yanlu, GUO Fenling, MAO Xiaoming. Construction of MRI radiomic prediction models for the differentiation of benign and malignant lesions of breast[J]. Journal of Molecular Imaging, 2021, 44(5): 764-770. doi: 10.12122/j.issn.1674-4500.2021.05.07

乳腺良恶性病变鉴别的MRI影像组学预测模型构建:基于随机森林、支持向量机、逻辑回归分类器

doi: 10.12122/j.issn.1674-4500.2021.05.07
基金项目: 

深圳市盐田区科技计划项目 YTWS20200204

详细信息
    作者简介:

    吴佩琪,硕士,医师,E-mail: 810997887@qq.com

    通讯作者:

    郭粉玲,主管技师,E-mail: fenglling@qq.com

Construction of MRI radiomic prediction models for the differentiation of benign and malignant lesions of breast

  • 摘要:   目的  构建基于随机森林、支持向量机和逻辑回归分类器的MRI影像组学预测模型,对乳腺良恶性病变进行鉴别,并评估上述模型的诊断价值。  方法  回顾性分析在南方科技大学盐田医院进行MRI影像检查并获得手术病理的34例乳腺病变患者的动态增强MRI图像。按0.8∶0.2的比例将病例分为训练集(n=27)和测试集(n=7)。采用3D Slicer软件勾画乳腺病灶靶区并生成3D感兴趣体积,对每个感兴趣体积提取1037个影像组学特征,使用LASSO进行影像组学特征降维,然后在训练集中采用随机森林、支持向量机和逻辑回归等3种分类器分别构建乳腺良恶性病变的预测模型,并在测试集中进行评估。  结果  经LASSO降维后共选出6个影像组学特征标签进行建模,3种模型在训练集中的分类效果均非常好(曲线下面积>0.90),其中稳定性最高的是基于逻辑回归分类器建立的乳腺良恶性病变影像组学预测模型。  结论  基于随机森林、支持向量机和逻辑回归的MRI影像组学预测模型在诊断乳腺良恶性病变方面都具有较好的诊断效能,其中逻辑回归模型更为稳定。影像组学方法可为乳腺良恶性病变的预测提供新的手段。

     

  • 图  1  患者年龄的小提琴图

    A:乳腺良性病变组和恶性病变组间患者的年龄差异无统计学意义(P>0.05);B:训练集和测试集中患者的年龄差异无统计学意义(P>0.05)

    Figure  1.  Violin chart of the age of the patients.

    图  2  1例左侧乳腺癌在DCE-MRI图像上手动勾画的3D感兴趣区体积结果

    A~C:分别显示轴位、冠状位和矢状位DCE-MRI图像上乳腺癌病灶区域靶区勾画(绿色区域);D:逐层进行乳腺癌靶区勾画后重建的3D感兴趣区体积结果

    Figure  2.  The 3D volume of interest result of manual delineation of the target area of the left breast cancer on the DCE-MRIimage.

    图  3  LASSO进行DCE-MRI影像组学特征降维的结果

    A:最佳惩罚系数λ的选择情况,在曲线最低点选择了最佳λ(0.0774);B:162个影像组学特征的惩罚系数图,随着惩罚系数λ的变化,大部分特征的系数压缩为0,最佳λ(0.0774)处选择了6个非零系数的影像组学特征。A和B中的垂直虚线表示采用5折交叉检验后所选取的最佳λ(0.0774).

    Figure  3.  The dimensionality reduction results of DCE-MRI based radiomic features by LASSO

    图  4  LASSO降维后6个惩罚系数非零的影像组学标签及其系数

    Figure  4.  The six radiomic signatures with non-zero penalty coefficients after LASSO dimensionality reduction and their coefficients.

    图  5  LASSO降维所得的各影像组学标签在乳腺良病变和恶性病变组间的差异的小提琴图

    A~F: wavelet-LLL_gldm_DependenceNonUniformityNormalized、log-sigma-5-0-mm-3D_ngtdm_Contrast、waveletLHL_glcm_MCC、wavelet-HHH_firstorder_90Percentile、orginal_shape_Sphericity和wavelet-HHL_LargeAreaHighGray LevelEmphasis在乳腺良性病变和恶性病变组间的差异.

    Figure  5.  Violin chart of the difference between the benign breast lesions and malignant breast lesions of each radiomic signatures obtained by LASSO dimensionality reduction (P < 0.05).

    图  6  3种影像组学预测模型在训练集中的ROC曲线

    A~C:分别表示RF、SVM和LR模型在训练集中的ROC曲线.

    Figure  6.  The ROC curve of the three radiomic prediction models in the training set

    图  7  3种影像组学预测模型在测试集中的ROC曲线

    A~C:分别表示RF、SVM和LR模型在测试集中的ROC曲线.

    Figure  7.  The ROC curve of the three radiomic prediction models in the test set.

    表  1  3种乳腺良恶性病变MRI影像组学预测模型在训练集中的诊断效能

    Table  1.   Diagnostic efficacy of the three MRI based radiomic prediction models for differentiating benign and malignant breast lesions in the training set

    模型 AUC 准确度 敏感度 特异性 阳性预测值 阴性预测值
    RF 0.980 0.889 0.769 1.000 1.000 0.824
    SVM 0.920 0.778 0.615 0.929 0.889 0.722
    LR 0.910 0.815 0.769 0.857 0.833 0.800
    RF: 随机森林; SVM: 支持向量机; LR: 逻辑回归; AUC: 曲线下面积.
    下载: 导出CSV

    表  2  3种乳腺良恶性病变MRI影像组学预测模型在测试集中的诊断效能

    Table  2.   Diagnostic efficacy of the three MRI based radiomic prediction models for differentiating benign and malignant breast lesions in the test set

    模型 AUC 准确度 敏感度 特异性 阳性预测值 阴性预测值
    RF 0.670 0.571 0.400 1.000 0.500 0.667
    SVM 0.750 0.714 0.285 0.750 0.667 0.750
    LR 0.750 0.714 0.400 0.600 0.667 0.750
    下载: 导出CSV
  • [1] Wild AE, Weiderpass E, Stewart BW, et al. World Cancer Report: Cancer Research for Cancer Prevention[M]. Lyon, France: International Agency for Research on Cancer, 2020: 25-7.
    [2] Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015 [J]. CA Cancer J Clin, 2016, 66(2): 115-32. doi: 10.3322/caac.21338
    [3] Miller KD, Nogueira L, Mariotto AB, et al. Cancer treatment and survivorship statistics, 2019[J]. CA Cancer J Clin, 2019, 69(5): 363-85. doi: 10.3322/caac.21565
    [4] Romanoff A, Constant TH, Johnson KM, et al. Association of previous clinical breast examination with reduced delays and earlier-stage breast cancer diagnosis among women in Peru[J]. JAMA Oncol, 2017, 3(11): 1563. doi: 10.1001/jamaoncol.2017.1023
    [5] Bicchierai G, di Naro F, de Benedetto D, et al. A review of breast imaging for timely diagnosis of disease[J]. Int J Environ Res Public Heal, 2021, 18(11): 5509. doi: 10.3390/ijerph18115509
    [6] An JY, Unsdorfer KML, Weinreb JC. BI-RADS, C-RADS, CADRADS, LI-RADS, Lung-RADS, NI-RADS, O-RADS, PI-RADS, TI-RADS: Reporting and data systems[J]. Radiographics, 2019, 39 (5): 1435-6. doi: 10.1148/rg.2019190087
    [7] Xiang W, Rao H, Zhou L. A meta-analysis of contrast-enhanced spectral mammography versus MRI in the diagnosis of breast cancer [J]. Thorac Cancer, 2020, 11(6): 1423-32. doi: 10.1111/1759-7714.13400
    [8] Lambin P, Leijenaar RTH, Deist TM, et al. Radiomics: the bridge between medical imaging and personalized medicine[J]. Nat Rev Clin Oncol, 2017, 14(12): 749-62. doi: 10.1038/nrclinonc.2017.141
    [9] Ye DM, Wang HT, Yu T. The application of radiomics in breast MRI: a review[J]. Technol Cancer Res Treat, 2020, 19: 1533033820916191. http://www.researchgate.net/publication/341011435_The_Application_of_Radiomics_in_Breast_MRI_A_Review
    [10] 陈文静, 牟伟, 张文馨, 等. 平扫T2脂肪抑制序列图像纹理可提高诊断乳腺良恶性结节的准确率[J]. 分子影像学杂志, 2019, 42 (4): 453-6. https://www.cnki.com.cn/Article/CJFDTOTAL-FZYX201904007.htm
    [11] Li W, Yu K, Feng CL, et al. Molecular subtypes recognition of breast cancer in dynamic contrast-enhanced breast magnetic resonance imaging phenotypes from radiomics data[J]. Comput Math Methods Med, 2019, 2019: 1-14. http://www.ncbi.nlm.nih.gov/pubmed/31827586
    [12] Zhou J, Lu J, Gao C, et al. Predicting the response to neoadjuvant chemotherapy for breast cancer: wavelet transforming radiomics in MRI[J]. BMC Cancer, 2020, 20(1): 100. doi: 10.1186/s12885-020-6523-2
    [13] Koh J, Lee E, Han K, et al. Three-dimensional radiomics of triplenegative breast cancer: Prediction of systemic recurrence[J]. Sci Rep, 2020, 10(1): 2976. doi: 10.1038/s41598-020-59923-2
    [14] Zheng X, Yao Z, Huang Y, et al. Deep learning radiomics can predict axillary lymph node status in early-stage breast cancer[J]. Nat Commun, 2020, 11(1): 1236. doi: 10.1038/s41467-020-15027-z
    [15] Crivelli P, Ledda RE, Parascandolo N, et al. A new challenge for radiologists: radiomics in breast cancer[J]. Biomed Res Int, 2018, 2018: 6120703.
    [16] Xu L, Yang P, Yen EA, et al. A multi-organ cancer study of the classification performance using 2D and 3D image features in radiomics analysis[J]. Phys Med Biol, 2019, 64(21): 215009. doi: 10.1088/1361-6560/ab489f
    [17] 吴佩琪, 林天武, 毛小明. MR影像组学特征在鉴别乳腺癌与乳腺纤维腺瘤中的应用[J]. 实用放射学杂志, 2019, 35(12): 1934-9. doi: 10.3969/j.issn.1002-1671.2019.12.012
    [18] Xie XJ, Liu SY, Chen JY, et al. Development of unenhanced CTbased imaging signature for BAP1 mutation status prediction in malignant pleural mesothelioma: Consideration of 2D and 3D segmentation[J]. Lung Cancer, 2021, 157(7): 30-9. http://www.sciencedirect.com/science/article/pii/S0169500221001641
    [19] Saha A, Harowicz MR, Mazurowski MA. Breast cancer MRI radiomics: an overview of algorithmic features and impact of inter-reader variability in annotating tumors[J]. Med Phys, 2018, 45(7): 3076- 85. doi: 10.1002/mp.12925
    [20] Reig B. Radiomics and deep learning methods in expanding the use of screening breast MRI[J]. Eur Radiol, 2021, 31(8): 5863-5. doi: 10.1007/s00330-021-08056-9
    [21] Massafra R, Bove S, Lorusso V, et al. Radiomic feature reduction approach to predict breast cancer by contrast-enhanced spectral mammography images[J]. Diagnostics, 2021, 11(4): 684. doi: 10.3390/diagnostics11040684
    [22] Granzier RWY, Ibrahim A, Primakov SP, et al. MRI-based radiomics analysis for the pretreatment prediction of pathologic complete tumor response to neoadjuvant systemic therapy in breast cancer patients: a multicenter study[J]. Cancers, 2021, 13(10): 2447. doi: 10.3390/cancers13102447
    [23] Daimiel Naranjo I, Gibbs P, Reiner JS, et al. Radiomics and machine learning with multiparametric breast MRI for improved diagnostic accuracy in breast cancer diagnosis[J]. Diagnostics, 2021, 11(6): 919. doi: 10.3390/diagnostics11060919
    [24] Montemezzi S, Benetti G, Bisighin MV, et al. 3T DCE-MRI radiomics improves predictive models of complete response to neoadjuvant chemotherapy in breast cancer[J]. Front Oncol, 2021, 11(4): 630780.
    [25] Meyer-Base A, Morra L, Tahmassebi A, et al. AI-enhanced diagnosis of challenging lesions in breast MRI: a methodology and application primer[J]. J Magn Reson Imaging, 2021, 54(3): 686-702. doi: 10.1002/jmri.27332
    [26] 贾巍, 宋瑞, 王勇, 等. 术前穿刺活检与术中冰冻病理诊断乳腺导管原位癌伴微浸润的准确性比较[J]. 广西医学, 2019, 41(22): 2854-5, 2858. https://www.cnki.com.cn/Article/CJFDTOTAL-GYYX201922011.htm
    [27] 高微波, 邓鹏飞, 杨全新, 等. 基于DCE-MRI影像组学鉴别乳腺良恶性肿块的可行性研究[J]. 临床放射学杂志, 2020, 39(4): 674-9. https://www.cnki.com.cn/Article/CJFDTOTAL-LCFS202004012.htm
    [28] Mao N, Yin P, Wang Q, et al. Added value of radiomics on mammography for breast cancer diagnosis: a feasibility study[J]. J Am Coll Radiol, 2019, 16(4 pt a): 485-91. http://www.onacademic.com/detail/journal_1000041588177999_5764.html
  • 加载中
图(7) / 表(2)
计量
  • 文章访问数:  495
  • HTML全文浏览量:  147
  • PDF下载量:  49
  • 被引次数: 0
出版历程
  • 收稿日期:  2021-06-15
  • 刊出日期:  2021-09-20

目录

    /

    返回文章
    返回

    关于《分子影像学杂志》变更刊期通知

    各位专家、作者、读者:

    为了缩短出版时滞,促进科研成果的快速传播,我刊自2024年1月起,刊期由双月刊变更为月刊。本刊主要栏目有:基础研究、临床研究、技术方法、综述等。

    感谢各位专家、作者、读者长期以来对我刊的支持与厚爱!

    南方医科大学学报编辑部

    《分子影像学杂志》

    2023年12月27日